If you may be in danger, call or text 988. Call 911 for emergencies. More crisis resources
For education, not medical advice. Always talk with your own doctor or prescriber about your treatment.
PsychiatryRx Part of The Shrink Network Medications. Understood.
Saved pages

Shariq Refai, MD, MBA, FAPA

Board-certified psychiatrist and medical editor

Joined the network: 2026-05-01 Last participation: 2026-07-15

Biography

Shariq Refai, MD, MBA, FAPA is a board-certified psychiatrist and the medical editor of PsychiatryRx. He also serves as medical editor of AnxietyResource, DepressionResource, and AnxietyResearch, and is the founder of shrinkMD, an independent multistate telepsychiatry practice. He reviews every guide on this site for clinical accuracy against current FDA labeling and published clinical practice guidelines before publication. His areas of practice interest include adult psychopharmacology, treatment-resistant depression, adult ADHD, and bipolar disorder maintenance.

Areas of expertise

  • General adult psychiatry
  • Psychopharmacology
  • Treatment-resistant depression
  • Anxiety disorders
  • Adult ADHD
  • Bipolar disorder maintenance

Disclosures

  • Founder of shrinkMD, an independent multistate telepsychiatry practice. Every page on PsychiatryRx that mentions shrinkMD carries an FTC 255 disclosure.
  • Author of published books; royalty income disclosed on shariqrefai.com.
  • No pharmaceutical company consulting, speaking, advisory, or research funding.
  • No affiliate, commission, or referral revenue from any prescriber or vendor for PsychiatryRx content.

Identifiers and affiliations

Pages reviewed

Dr. Refai reviews every guide on PsychiatryRx for clinical accuracy against current FDA labeling and published clinical practice guidelines. See the full page manifest for the complete list. Every content page displays this reviewer's name and the last-reviewed date.